All Updates

All Updates

icon
Filter
Funding
EvolutionaryScale raises USD 142 million in seed funding to develop protein-generating AI models
AI Drug Discovery
Jun 25, 2024
This week:
Partnerships
Anthropic partners with Amazon Bedrock to fine-tune Claude 3 Haiku model
Foundation Models
Yesterday
Funding
Lemon.markets raises EUR 12 million in funding to support growth
FinTech Infrastructure
Yesterday
M&A
Kipu Quantum acquires PlanQK platform to enhance accessibility to quantum computing solutions
Quantum Computing
Yesterday
Partnerships
Quantinuum and STFC Hartree Centre partner to enhance quantum computing accessibility in UK
Quantum Computing
Yesterday
M&A
Ipsen licenses Foreseen's antibody-drug conjugate 'FS001' for first-in-class cancer treatment development
Precision Medicine
Yesterday
M&A
Ipsen licenses Foreseen's antibody-drug conjugate 'FS001' for first-in-class cancer treatment development
AI Drug Discovery
Yesterday
Partnerships
Beacon Therapeutics collaborates with Abeona Therapeutics for ophthalmic gene therapy development
Cell & Gene Therapy
Yesterday
Funding
Pan Cancer T raises EUR 4.25 million in seed extension funding for preclinical studies of PCT1:CO-STIM TCR T-cell therapy
Cell & Gene Therapy
Yesterday
Partnerships
Accelerated Biosciences and Pluristyx partner to create clinical-grade induced pluripotent stem cell lines
Cell & Gene Therapy
Yesterday
M&A
SoftBank acquires UK AI chipmaker Graphcore to improve AI capabilities
Edge Computing
Yesterday
AI Drug Discovery

AI Drug Discovery

Jun 25, 2024

EvolutionaryScale raises USD 142 million in seed funding to develop protein-generating AI models

Funding

  • GenAI-powered protein generator EvolutionaryScale has raised USD 142 million in a seed round led by Nat Friedman, Daniel Gross, and Lux Capital, with participation from Amazon and NVenture, NVIDIA's venture arm.

  • The funds will be directed toward scaling up its model training to include data beyond proteins and to construct a uniquely versatile AI model relevant to biotech applications. Its ESM3 model is claimed to be trained on 2.78 billion proteins, allowing it to generate novel proteins intended for use in scientific discovery and material science. 

  • EvolutionaryScale is an AI biotechnology company that leverages advanced AI models to predict protein structures to support drug development, environmental remediation, and other biotech applications. Founded in 2023, the company’s technology builds on transformers-based models specialized in biological data, particularly protein molecules.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.